Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer

British Journal of Surgery

Volumn 91, Issue 1, 2004, Pages 54-60

  Jain, P K ^a   Sowdi, R ^a   Anderson, A D G ^a   MacFie, J ^a  

^a SCARBOROUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FIBRIN GLUE; WARFARIN;

ADULT; AGED; BREAST CANCER; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRAIN; EVALUATION; HOSPITALIZATION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MASTECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEROMA; STATISTICAL SIGNIFICANCE; SUCTION DRAINAGE; TREATMENT OUTCOME;

BREAST NEOPLASMS; DRAINAGE; FEMALE; FIBRIN TISSUE ADHESIVE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MASTECTOMY; MIDDLE AGED; PAIN, POSTOPERATIVE; POSTOPERATIVE COMPLICATIONS; TISSUE ADHESIVES; TREATMENT OUTCOME;

EID: 1642499223     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4435     Document Type: Conference Paper

References (35)

1. Roses DF, Brooks AD, Harris MN, Shapiro RL, Mimick J. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg 1999; 230: 194-201.
2. Woodworth PA, McBoyle MF, Helmer SD, Beamer RL. Seroma formation after breast cancer surgery: incidence and predicting factors. Am Surg 2000; 66: 444-451.
3. Classe JM, Dupre PF, Francois T, Robard S, Theard JL, Dravet F. Axillary padding as an alternative to closed suction drain for ambulatory axillary lymphadenectomy: a prospective cohort of 207 patient with early breast cancer. Arch Surg 2002; 137: 169-173.
4. Abe M, Iwase T, Takeuchi T, Murai H, Miura S. A randomized controlled trial on the prevention of seroma after partial or total mastectomy and axillary lymph node dissection. Breast Cancer 1998; 5: 67-69.
5. Somers RG, Jablon LK, Kaplan MJ, Sandler GL, Rosenblatt NK. The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer: a prospective randomized trial. Ann Surg 1992; 215: 146-149.
6. Purushotham AD, McLatchie E, Young D, George WD, Stallard S, Doughty J et al. Randomized clinical trial of no wound drains and early discharge in the treatment of women with breast cancer. Br J Surg 2002; 89: 286-292.
7. Siegel BM, Mayzel KA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 1990; 125: 1144-1147.
8. Liu CD, McFadden DW. Overnight closed suction drainage after axillary lymphadenectomy for breast cancer. Am Surg 1997; 63: 868-870.
9. Yu M, Murphy C, Orr N. Early removal of drains and discharge of breast cancer surgery patients: a controlled prospective clinical trial. Ann R Coll Surg Engl 1995; 77: 377-379.
10. Kopelman D, Klemm O, Bahous H, Klein R, Krausz M, Hashmonai M. Postoperative suction drainage of the axilla: for how long? Prospective randomised trial. Eur J Surg 1999; 165: 117-120.
11. Bundred N, Maguire P, Reynolds J, Grimshaw J, Morris J, Thomson L et al. Randomised controlled trial of effects of early discharge after surgery for breast cancer. BMJ 1998; 317: 1275-1279.
12. Edwards MJ, Broadwater RJ, Bell JL, Ames FC, Balch CM. Economic impact of reducing hospitalization for mastectomy patients. Ann Surg 1988; 208: 330-336.
13. Holcombe C, West N, Mansel RE, Horgan K. The satisfaction and savings of early discharge with drain in situ following axillary lymphadenectomy in the treatment of breast cancer. Eur J Surg Oncol 1995; 21: 604-606.
14. Watt-Boolsen S, Nielsen VB, Jensen J, Bak S. Postmastectomy seroma. A study of the nature and origin of seroma after mastectomy. Dan Med Bull 1989; 36: 487-489.
15. Kulber DA, Bacilious N, Peters ED, Gayle LB, Hoffman L. The use of fibrin sealant in the prevention of seromas. Plast Reconstr Surg 1997; 99: 842-849.
16. Harada RN, Pressler VM, McNamara JJ. Fibrin glue reduces seroma formation in the rat after mastectomy. Surg Gynecol Obstet 1992; 175: 450-454.
17. Wang JY, Goodman NC, Amiss LR Jr, Nguyen DH, Rodeheaver GT, Moore MM et al. Seroma prevention in a rat mastectomy model: use of a light-activated fibrin sealant. Ann Plast Surg 1996; 37: 400-405.
18. Moore M, Burak WE Jr, Nelson E, Kearney T, Simmons R, Mayers L et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg 2001; 192: 591-599.
19. Gilly FN, Francois Y, Sayag-Beaujard AC, Glehen O, Brachet A, Vignal J. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur Surg Res 1998; 30: 439-443.
20. Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-1194.
21. Paramothayan NS, Barron J. New criteria for the differentiation between transudates and exudates. J Clin Pathol 2002; 55: 69-71.
22. Boyer TD, Kahn AM, Reynolds TB. Diagnostic value of ascetic fluid lactic dehydrogenase, protein, and WBC levels. Arch Intern Med 1978; 138: 1103-1105.
23. Say CC, Donegan W. A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet 1974; 138: 370-376.
24. O'Hea BJ, Ho MN, PetrekJA. External compression dressing versus standard dressing after axillary lymphadenectomy. Am J Surg 1999; 177: 450-453.
25. Dawson I, Stam L, Heslinga JM, Kalsbeek HL. Effect of shoulder immobilization on wound seroma and shoulder dysfunction following modified radical mastectomy: a randomized prospective clinical trial. Br J Surg 1989; 76: 311-312.
26. O'Dwyer PJ, O'Higgins NJ, James AG. Effect of closing dead space on incidence of seroma after mastectomy. Surg Gynecol Obstet 1991; 172: 55-56.
27. Porter KA, O'Connor S, Rimm E, Lopez M. Electrocautery as a factor in seroma formation following mastectomy. Am J Surg 1998; 176: 8-11.
28. Aitken DR, Hunsaker R, James AG. Prevention of seromas following mastectomy and axillary dissection. Surg Gynecol Obstet 1984; 158: 327-330.
29. Petrek JA, Peters MM, Cirrincione C, Thaler HT. A prospective randomized trial of single versus multiple drains in the axilla after lymphadenectomy. Surg Gynecol Obstet 1992; 175: 405-409.
30. van Heurn LW, Brink PR. Prospective randomized trial of high versus low vacuum drainage after axillary lymphadenectomy. Br J Surg 1995; 82: 931-932.
31. Jeffrey SS, Goodson WH III, Ikeda DM, Birdwell RL, Bogetz MS, Guiliano A et al. Axillary lymphadenectomy for breast cancer without axillary drainage. Arch Surg 1995; 130: 909-913.
32. Burak WE Jr, Goodman PS, Young DC, Farrar WB. Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. J Surg Oncol 1997; 64: 27-31.
33. Langer S, Guenther M, GiFronzo A. Does fibrin sealant reduce drain output and allow earlier removal of drainage catheter in women undergoing operation for breast cancer? Am Surg 2003; 69: 77-81.
34. Dinsmore RC, Harris JA, Gustafson RJ. Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. Am Surg 2000; 66: 982-985.
35. Sanders RP, Goodman NC, Amiss LR Jr, Pierce RA, Moore MM, Marx G et al. Effect of fibrinogen and thrombin concentrations on mastectomy seroma prevention. J Surg Res 1996; 61: 65-70.